| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
3.652 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
CCNB1 |
Cyclin B1 |
3.652 |
Evidence |
|
| STXBP3 |
STXBP3: Syntaxin-binding protein 3 |
STX4A |
STX4, STX4A: Syntaxin-4 |
3.627 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
3.622 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
3.61 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
3.607 |
Evidence |
|
| INHBB |
INHBB: Inhibin beta B chain precursor |
INHBC |
INHBC: Inhibin beta C chain precursor |
3.6 |
Evidence |
O
|
| BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
BMPR1A |
BMPR1A, ACVRLK3, ALK3: Bone morphogenetic protein receptor type IA precursor |
3.6 |
Evidence |
O
|
| PLG |
PLG: Plasminogen precursor |
MMP3 |
MMP3, STMY1: Stromelysin-1 precursor |
3.6 |
Evidence |
|
| MAF |
MAF: Transcription factor Maf |
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
3.6 |
Evidence |
|
| COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
COPS7A |
COPS7A, CSN7A, DERP10: COP9 signalosome complex subunit 7a |
3.58 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
3.575 |
Evidence |
|
| COPS6 |
COPS6, CSN6, HVIP: COP9 signalosome complex subunit 6 |
COPS3 |
COPS3, CSN3: COP9 signalosome complex subunit 3 |
3.572 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
LMO2 |
LMO2, RBTN2, RBTNL1, RHOM2, TTG2: Rhombotin-2 |
3.547 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
3.525 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
GNAI2 |
Galphai2 protein |
3.525 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
3.51 |
Evidence |
|
| RGL2 |
RGL2, RAB2L: Ral guanine nucleotide dissociation stimulator-like 2 |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
3.497 |
Evidence |
|
| CAV1 |
CAV1, CAV: Caveolin-1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
3.495 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
3.477 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
3.477 |
Evidence |
|
| PTPN11 |
IPI00298347 |
JAK1 |
|
3.47 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
3.47 |
Evidence |
|
| CREBBP |
CREBBP, CBP: CREB-binding protein |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.452 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NUP153 |
IPI00514528 |
3.452 |
Evidence |
|
